JPML Weighs New Opioid MDL As McKinsey Suits Surge
New multidistrict litigation probably won't streamline dozens of cases accusing McKinsey & Co. of helping drugmakers aggressively market prescription opioids, but squeezing the cases into a long-running opioid MDL might be...To view the full article, register now.
Already a subscriber? Click here to view full article